A missense variant, p.(Ile269Asn), in MC4R as a secondary finding in a child with BCL11A-related intellectual disability

Eur J Med Genet. 2020 Sep;63(9):103969. doi: 10.1016/j.ejmg.2020.103969. Epub 2020 Jun 10.

Abstract

We describe a three year old female who underwent clinical exome sequencing and was diagnosed with BCL11A-related intellectual disability/Dias-Logan syndrome due to a de novo, heterozygous variant in the BCL11A gene, NM_018014.3:c.148C > T; p.(Gln50*). A missense variant in MC4R, NM_005912.3:c.806T > A; p.(Ile269Asn), was also reported as a secondary finding. In her family, her father, paternal aunt, and paternal uncle were all reported to have height and weight measurements suggestive of Class 3 obesity with BMI>40 kg/m2. The MC4R gene is not currently listed among those recommended for reporting of secondary findings by the American College of Medical Genetics and Genomics (ACMG). The identification of genetic risk factors for obesity is an emerging field without established guidelines for the care of patients who are found to have a predisposing genetic variant for obesity as a secondary finding. Management suggestions include interventions for weight-management, early screening for obesity-related co-morbidities, such as diabetes and dyslipidemia, and targeted therapies, such as MC4R agonists.

Keywords: BCL11A; Developmental delay; Dias-Logan syndrome; Intellectual disability; MC4R; Obesity; Secondary findings.

Publication types

  • Case Reports
  • Letter

MeSH terms

  • Child, Preschool
  • Developmental Disabilities / genetics*
  • Developmental Disabilities / pathology
  • Female
  • Humans
  • Intellectual Disability / genetics*
  • Intellectual Disability / pathology
  • Mutation, Missense*
  • Receptor, Melanocortin, Type 4 / genetics*
  • Repressor Proteins / genetics*

Substances

  • BCL11A protein, human
  • MC4R protein, human
  • Receptor, Melanocortin, Type 4
  • Repressor Proteins